Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.55 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8480725 | 0.94 | HTR1A (0.60) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6581590 | 0.88 | HTR1A (0.50) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6583413 | 0.88 | ADRB1 (0.50) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6583539 | 0.87 | HTR1A (0.50) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6584789 | 0.87 | HTR1A (0.56) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6583537 | 0.87 | HTR1A (0.50) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6585688 | 0.87 | HTR1A (0.50) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6581720 | 0.86 | HTR1A (0.49) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6582484 | 0.84 | HTR1A (0.47) | HTR1AALDH1A1LMNACYP3A4ALOX12 | |
| SCHEMBL6583374 | 0.84 | HTR1A (0.58) | HTR1AALDH1A1LMNACYP3A4ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0861837-B1 | 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2004-04-28 | — | — | EP | claimed |
| US-5968954-A | EXHIBIT SELECTIVE BINDING AFFINITY FOR 5-HYDROXYTRYPTAMINE RECEPTORS | ADIR ET COMPAGNIE (FR) | 1999-10-19 | — | — | US | claimed |
| EP-0861837-A1 | 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1998-09-02 | — | — | EP | claimed |
| JP-10237071-A | — | — | None | — | — | JP | disclosed |
| EP-0861837-B1 | 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2004-04-28 | — | — | EP | disclosed |
| US-5968954-A | EXHIBIT SELECTIVE BINDING AFFINITY FOR 5-HYDROXYTRYPTAMINE RECEPTORS | ADIR ET COMPAGNIE (FR) | 1999-10-19 | — | — | US | disclosed |
| JP-H10237071-A | NEW 2-AMINOINDANE COMPOUND, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | ADIR | 1998-09-08 | — | — | JP | disclosed |
| EP-0861837-A1 | 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1998-09-02 | — | — | EP | disclosed |